Market revenue in 2022 | USD 61.4 million |
Market revenue in 2030 | USD 125.9 million |
Growth rate | 9.4% (CAGR from 2022 to 2030) |
Largest segment | Consumables & accessories |
Fastest growing segment | Consumables & Accessories |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Consumables & Accessories |
Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Agilent Technologies, PerkinElmer, BD, Danaher Corp, Bio-Rad Laboratories Inc, Biotek, GE HealthCare Technologies Inc Common Stock |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell counting market will help companies and investors design strategic landscapes.
Consumables & accessories was the largest segment with a revenue share of 62.38% in 2022. Horizon Databook has segmented the Mexico cell counting market based on instruments, consumables & accessories covering the revenue growth of each sub-segment from 2018 to 2030.
The Mexico cell counting market is expected to grow at a high CAGR during the forecast period owing to rising healthcare spending by people, growing opportunities for biologics manufacturers, and increasing medical tourism in this region.
Mexico is a popular destination for the U.S. and Canada citizens pursuing treatment at minimum cost. Proximity to the U.S. and lower travel costs have been encouraging people in Canada and America to avail various treatments including stem cell therapy in Mexico.
Baja Orthopedics and Hospital Angeles are some of the private hospitals in Mexico that provide stem cell therapy for various chronic conditions. Thus, patients from developed countries such as the U.S., Germany, the UK, and other European countries are expected to travel to Mexico for the treatment of diseases such as diabetes, Alzheimer's, Parkinson's, multiple sclerosis, heart disease, and blood cancer.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico cell counting market, including forecasts for subscribers. This country databook contains high-level insights into Mexico cell counting market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account